
Global Cord Blood Corporation CO
Annual report 2022
added 08-16-2022
Country |
|
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NYSE |
Shares |
122 M |
Market Cap[1] |
$ 399 M |
EBITDA (LTM) |
$ 595 M |
P/E (LTM) |
0.73 |
P/S (LTM) |
0.34 |
EPS (LTM) |
4.09 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Biomerica
BMRA
|
$ 2.18 | -0.46 % | $ 5.01 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Brainsway Ltd.
BWAY
|
$ 13.35 | -2.31 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 25.79 | 3.16 % | $ 716 M | Nasdaq Global Market,SPB | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 197.61 | 1.2 % | $ 21.9 B | NYSE,SPB | ||
|
Danaher Corporation
DHR
|
$ 192.89 | 1.87 % | $ 137 B | NYSE,SPB | ||
|
DexCom
DXCM
|
$ 68.04 | 1.63 % | $ 26.5 B | Nasdaq Global Select Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Exact Sciences Corporation
EXAS
|
$ 104.91 | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 16.21 | 4.48 % | $ 490 M | Nasdaq Global Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 129 M | Nasdaq Capital Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Charles River Laboratories International
CRL
|
$ 156.89 | 2.14 % | $ 7.78 B | NYSE,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Interpace Biosciences
IDXG
|
$ 1.7 | - | $ 7.46 M | Nasdaq Global Select Market | ||
|
IDEXX Laboratories
IDXX
|
$ 588.96 | 2.03 % | $ 47.4 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 124.33 | - | $ 19.8 B | Nasdaq Global Select Market,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
BioNano Genomics
BNGO
|
$ 1.3 | 13.04 % | $ 1.65 M | Nasdaq Capital Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 169.0 | 1.75 % | $ 29.1 B | NYSE,SPB | ||
|
Agilent Technologies
A
|
$ 113.21 | 1.72 % | $ 34.4 B | NYSE,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 103.03 | 3.34 % | $ 8.5 B | Nasdaq Global Select Market,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 7.5 | -6.13 % | $ 29.9 M | Nasdaq Capital Market | ||
|
Guardant Health
GH
|
$ 86.93 | 2.05 % | $ 10.9 B | Nasdaq Global Select Market,SPB | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Biodesix
BDSX
|
$ 15.63 | 5.08 % | $ 2.03 B | Nasdaq Global Market | ||
|
CareDx, Inc
CDNA
|
$ 17.48 | 1.92 % | $ 931 M | Nasdaq Global Market,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 76.49 | 0.08 % | $ 5.16 B | Nasdaq Global Select Market,SPB | ||
|
Bioventus
BVS
|
$ 8.94 | 3.47 % | $ 596 M | Nasdaq Global Select Market | ||
|
Medpace Holdings
MEDP
|
$ 458.87 | 1.41 % | $ 13.2 B | Nasdaq Global Select Market,SPB | ||
|
Celcuity
CELC
|
$ 105.6 | -0.41 % | $ 4.17 B | Nasdaq Global Select Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 268.27 | 1.97 % | $ 22.3 B | NYSE,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 244.18 | 3.3 % | $ 25.6 B | NYSE,SPB | ||
|
Myriad Genetics
MYGN
|
$ 4.81 | 5.02 % | $ 445 M | Nasdaq Global Select Market,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 3.3 | -4.35 % | $ 1.77 M | Nasdaq Global Select Market | ||
|
NeoGenomics
NEO
|
$ 8.31 | 4.33 % | $ 1.06 B | Nasdaq Global Select Market,SPB | ||
|
National Research Corporation
NRC
|
$ 17.11 | -1.24 % | $ 383 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 198.64 | 1.72 % | $ 19.5 B | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.